Research is fundamental to Sanesco’s mission. The knowledge gained from this effort deepens an understanding of the body’s Communication System, identifies new biochemical targets in this system, and provides the impetus for innovative therapeutic treatment protocols within the Communication System Management (CSM) model.

Sanesco has invested considerable resources to establish an in-house research department. Initially, the company focused on the function of HP (hypothalamic-pituitary) and HPA (hypothalamic-pituitary-adrenal) axes—systems that are critical to all metabolic function—in the development of its TNT formulations and treatment protocols. During this phase, Sanesco then undertook a clinical study that was designed to quantify the effectiveness of its formulas on patients reporting a broad spectrum of symptoms. The results of that study were used to guide the development of the functional assessments (serial tests) and Targeted Nutritional Therapy (TNT) formulas that Sanesco currently offers.
The next phase of Sanesco’s research is already underway. Focusing on the HPT (hypothalamic-pituitary-thyroid) axis, this effort will broaden the knowledge of the Communication System and lead to the development of the next level of therapeutic options within the CSM model. Once again, Sanesco is working closely with practitioners to bring innovative technologies and therapies from the laboratory into the clinic in the most efficient and rapid manner possible.
Sanesco’s multi-disciplinary team of researchers, physicians, naturopathic doctors and nutritionists guide the research and development process every step of the way. Their expertise is invaluable in the development of each serial test and TNT formula that Sanesco offers. They are a primary resource upon which practitioners can rely for the analysis and interpretation of patient tests and symptoms, and for recommended treatment options.
For practitioners of integrative medicine, the future holds great promise. Equipped with the latest knowledge of the Communication System and supported by Sanesco’s ever-evolving CSM model, the opportunity to positively affect the healing and long-term health of patients has never been better.





